Press release
Analysis of Key Market Segments Influencing the Non-Viral Gene Delivery Technologies Market
Non-Viral Gene Delivery Technologies Market
Non-Viral Gene Delivery Technologies Market Size and Projected Growth Through 2030
The non-viral gene delivery technologies market is forecasted to grow rapidly, reaching a valuation of $9.26 billion by 2030. This represents a compound annual growth rate (CAGR) of 15.1% over the coming years. The anticipated market surge is fueled by advances in lipid and polymer nanoparticle development, wider availability of pre-formulated nanoparticle technologies, increased investments in gene editing and RNA interference (RNAi) therapeutics, and a rising demand for personalized gene therapy solutions. Additionally, the integration of automated and high-throughput delivery platforms is set to further propel the market forward. Key market trends include greater adoption of lipid- and polymer-based non-viral delivery systems, growth in CRISPR and Cas9 gene editing applications, rising use of RNAi and DNA vaccine delivery platforms, expansion of ex-vivo and in-vivo gene therapy research, and the development of targeted, cell-specific gene delivery reagents.
Download a free sample of the non-viral gene delivery technologies market sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27367&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Key Factors Stimulating the Non-Viral Gene Delivery Technologies Market
Leading companies in this market are focusing heavily on creating sophisticated non-viral genetic medicine platforms that enhance the safety and effectiveness of gene therapies. These platforms enable delivery of therapeutic genes or nucleic acids into cells without relying on viral vectors, which minimizes immune responses and safety issues. This approach allows for more precise and controlled gene therapy treatments across various diseases.
A notable example occurred in October 2023 when Generation Bio, a US biotechnology firm specializing in genetic medicines, introduced immune-quiet DNA (iqDNA). This advanced form of their closed-ended DNA is designed to avoid detection by the innate immune system. When administered via their lipid nanoparticle system, iqDNA demonstrated cytokine levels and tolerability comparable to chemically modified mRNA in animal studies involving mice and non-human primates. Thanks to its enhanced safety profile, Generation Bio is prioritizing iqDNA as the main DNA cargo in all its therapeutic programs, including its lead treatment for hemophilia A.
View the full non-viral gene delivery technologies market report:
https://www.thebusinessresearchcompany.com/report/non-viral-gene-delivery-technologies-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Companies Influencing the Non-Viral Gene Delivery Technologies Market
Several key players dominate the non-viral gene delivery technologies landscape, including Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Evonik Industries AG, Moderna Inc., Lonza Group AG, Bio-Rad Laboratories Inc., Takara Bio Inc., GenScript Biotech Corporation, ReCode Therapeutics Inc., Altogen Biosystems Inc., Generation Bio, and Indee Labs Inc.
In a significant development in September 2023, US pharmaceutical company SOHM Inc., which specializes in generic and private-label drugs, acquired ABBIE Inc. for an undisclosed sum. This acquisition boosts SOHM's capabilities in non-viral gene delivery technologies and strengthens its position in advanced gene-editing solutions. ABBIE Inc. is known for its gene-editing platform that delivers genetic payloads using non-viral vectors.
Current Trends Accelerating Growth in Non-Viral Gene Delivery Technologies
Innovation within the non-viral gene delivery market is largely driven by efforts to develop gene medicine platforms that improve therapeutic safety and efficiency. These platforms introduce therapeutic material into cells without viruses, reducing immune system activation and enhancing treatment precision.
Another trend is the rise of novel DNA constructs and delivery methods aimed at evading immune detection, as seen with Generation Bio's iqDNA. This trend supports the development of more tolerable and effective gene therapies for a variety of diseases, demonstrating increased focus on patient safety and treatment efficacy within the field.
How the Non-Viral Gene Delivery Technologies Market is Structured
This market is categorized based on several key dimensions:
1) Product Type: Reagents and Kits, Delivery Devices, Pre-Formulated Nanoparticles
2) Delivery Method: In-Vitro, In-Vivo, Ex-Vivo
3) Technology: Electroporation, Lipid-Based Transfection, Polymer-Based Transfection, Physical Methods (including Microinjection and Gene Gun), Nanoparticles
4) Application: Gene Therapy, DNA Vaccines, RNA Interference (RNAi), CRISPR/Cas9 Gene Editing, Protein Expression
5) End-Use Sector: Biotechnology and Biopharmaceutical Companies, Research and Academic Institutes, Other Users
Further breakdown includes:
- Reagents and Kits: Transfection Reagents, Plasmid DNA Kits, mRNA Delivery Kits, siRNA Delivery Kits, CRISPR-Associated Protein Reagents, Cell-Specific Delivery Reagents
- Delivery Devices: Electroporation Systems, Microinjection Tools, Gene Guns/Biolistic Devices, Ultrasound-Mediated Delivery Devices, Hydrodynamic Gene Delivery Systems
- Pre-Formulated Nanoparticles: Lipid-Based Nanoparticles, Polymer-Based Nanoparticles, Gold-Based Nanoparticles, Dendrimer-Based Nanoparticles, Carbon Nanotube-Based Nanoparticles, Inorganic Compound-Based Nanoparticles
This segmentation provides a detailed overview of the technologies, products, and applications shaping the future of non-viral gene delivery.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Analysis of Key Market Segments Influencing the Non-Viral Gene Delivery Technologies Market here
News-ID: 4499854 • Views: …
More Releases from The Business Research Company
Ophthalmic Drugs Market Perspective: Major Segments, Strategic Developments, and …
The ophthalmic drugs market is on track for significant expansion in the coming years, driven by advances in drug delivery technology and increasing global awareness about eye health. As eye conditions become more prevalent and treatments evolve, the market is poised to experience notable growth through 2030. Let's explore the current landscape, major players, emerging trends, and key segments shaping this dynamic industry.
Projected Growth and Market Size of the Ophthalmic…
In-Depth Examination of Segments, Industry Developments, and Key Players in the …
The oncology adjuvants market is on the brink of significant expansion, driven by advancements in cancer treatment and innovative therapeutic approaches. As breakthroughs in immunotherapy and precision medicine continue to evolve, this market is expected to play a critical role in improving cancer patient outcomes over the coming years. Below is an overview of the market's size, key players, emerging trends, and important segment details.
Forecasted Market Growth and Size of…
Segment Analysis and Major Growth Areas in the Omega 3 Prescription Drugs Market
The omega 3 prescription drugs market is poised for significant expansion over the coming years, driven by innovations in medicine and growing consumer interest in tailored therapies. This sector is set to benefit from technological advancements and a broader reach into emerging markets, positioning itself for robust growth through 2030.
Anticipated Market Size and Growth Trajectory for Omega 3 Prescription Drugs
Forecasts indicate that the omega 3 prescription drugs market…
Top Firms and Competitive Dynamics in the Occupational Medicines Market
The occupational medicines sector is poised for significant advancement as the workforce faces increasing health challenges and regulatory demands. With a growing emphasis on worker well-being and safety, this market is expected to witness steady growth fueled by several key factors and innovative approaches. Let's explore the current market valuation, driving forces, prominent players, emerging trends, and segmentation details shaping this dynamic industry.
Projected Growth and Valuation of the Occupational Medicines…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
